T cell responses to Mycobacterium indicus pranii immunotherapy and adjunctive glucocorticoid therapy in tuberculous pericarditis
Open Access
- 14 June 2022
- journal article
- research article
- Published by Elsevier in Vaccine: X
- Vol. 11, 100177
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Prednisolone andMycobacterium indicus praniiin Tuberculous PericarditisNew England Journal of Medicine, 2014
- Immunotherapy for Tuberculous PericarditisNew England Journal of Medicine, 2014
- Efficacy of Mycobacterium indicus pranii Immunotherapy as an Adjunct to Chemotherapy for Tuberculosis and Underlying Immune Responses in the LungPLOS ONE, 2012
- Functional Capacity of Mycobacterium tuberculosis-Specific T Cell Responses in Humans Is Associated with Mycobacterial LoadThe Journal of Immunology, 2011
- SPICE: Exploration and analysis of post‐cytometric complex multivariate datasetsCytometry Part A, 2011
- Pathological role of interleukin 17 in mice subjected to repeated BCG vaccination after infection with Mycobacterium tuberculosisJournal of Experimental Medicine, 2010
- Tuberculous PericarditisCirculation, 2005
- Diagnosis of tuberculous aetiology in pericardial effusionsPostgraduate Medical Journal, 2004
- Pericardial Disease: An Evidence‐Based Approach to Diagnosis and Treatment2002
- Tuberculous PericarditisJAMA, 1991